معرفی
Noffar Bar, MD, is an Assistant Professor of Medicine (Hematology) at Yale School of Medicine. She specializes in multiple myeloma and plasma cell disorders, with expertise in CAR T-cell therapy, stem cell transplantation, and clinical trials. Dr. Bar completed her medical degree at the American Medical Program at Tel Aviv University (2009) and her BA at Tufts University (2005). She is affiliated with the Multiple Myeloma and Gammopathies Program, Cardiac Amyloidosis Program, and Yale Cancer Center.
Her research focuses on improving treatments for multiple myeloma patients, including novel therapies like CAR T-cell redirection. She has received grants from the Conquer Cancer Foundation and awards for her research on myeloma prevention. Dr. Bar is also a medical educator, promoting high-value care in hematology.
- Awards: Young Investigator Award (Conquer Cancer Foundation), Hematology Oncology Fellowship Program Annual Research Award.
- Clinical Trials: Sub-investigator in trials evaluating CAR T-cell therapies, daratumumab regimens, and novel drug combinations.
Her work emphasizes patient-reported outcomes and minimizing treatment toxicity, with ongoing studies on T-cell fitness and MRD negativity in myeloma therapies.
